For the Inventor, By the Inventor

Enter inventor name

Indianapolis, IN, United States of America

Stacey L McDaniel

USPTO Granted Patents = 14

Average Co-Inventor Count = 12.2

ph-index = 4

Forward Citations = 54(Granted Patents)

Location History:

Bloomington, IN (US) (2003)
Martinsville, IN (US) (2000 - 2005)
Indianapolis, IN (US) (2003 - 2005)

Company Filing History:

Eli Lilly and Company

Elan Pharmaceuticals, Inc.

Athena Neurosciences, Inc.

4. 10 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2005

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6958330 - Polycyclic α-amino-ε-caprolactams and related compounds (2005-10-25),

2. 6951854 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds (2005-10-04),

3. 6906056 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds (2005-06-14),

4. 6683075 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use (2004-01-27),

5. 6667305 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-12-23),

6. 6653303 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-11-25),

7. 6635632 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-10-21),

8. 6632811 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-10-14),

9. 6579867 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-06-17),

10. 6569851 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-05-27),

11. 6559141 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-05-06),

12. 6544978 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-04-08),

13. 6541466 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2003-04-01),

14. 6107307 - Inhibition of serotonin reuptake (2000-08-22),

Title: The Innovative Journey of Stacey L. McDaniel

Introduction

Stacey L. McDaniel is a prominent inventor based in Indianapolis, Indiana, with a remarkable portfolio comprising 14 patents. Her innovative contributions primarily focus on pharmaceutical compositions and methods for addressing critical health issues, including Alzheimer’s disease.

Latest Patents

Among her notable patents, Stacey has made significant strides with her latest inventions, including the development of polycyclic α-amino-ε-caprolactams and related compounds. These inventive compounds serve as vital synthetic intermediates in the creation of inhibitors for β-amyloid peptide release and its synthesis. Additionally, her patent on cycloalkyl, lactam, lactone, and related compounds delineates their effectiveness in preventing β-amyloid peptide release, thus offering promising therapeutic applications for Alzheimer’s disease. Moreover, the associated pharmaceutical compositions create new avenues for preventing and treating this challenging condition both prophylactically and therapeutically.

Career Highlights

Stacey McDaniel’s career is marked by her impressive work at Eli Lilly and Company, where she played a crucial role in pharmaceutical innovation and advancement. Her dedication to research and development has significantly contributed to the company's goals in improving health outcomes.

Collaborations

Throughout her career, Stacey has collaborated with accomplished professionals in her field, including colleagues Thomas Edward Mabry and Warren Jaye Porter. These partnerships have fostered a creative environment that encourages innovative thinking and practical solutions to complex health issues.

Conclusion

Stacey L. McDaniel’s contributions to the field of pharmaceuticals through her patents and collaborations reflect her commitment to innovation in science. Her ongoing efforts continue to pave the way for advancements that can potentially change the lives of those affected by Alzheimer’s disease and other health concerns, making her a notable figure in the realm of invention.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…